Effect of requiring advance approval of chemotherapy on number and cost of ungiven doses

Am J Health Syst Pharm. 2011 Apr 1;68(7):557-8. doi: 10.2146/ajhp090664.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / economics*
  • Costs and Cost Analysis
  • Drug Compounding / economics*
  • Drug Compounding / standards
  • France
  • Humans
  • Pharmacy Service, Hospital / economics*
  • Pharmacy Service, Hospital / legislation & jurisprudence*
  • Pharmacy Service, Hospital / standards

Substances

  • Antineoplastic Agents